Summary:
US Patent 9,688,711 covers a specific pharmaceutical compound or formulation with claims focused on its chemical structure, method of preparation, or therapeutic use. The patent’s scope restricts its claims to particular molecular structures, methods of synthesis, and specified indications. The patent landscape reveals active patenting by competitors around similar compounds, with significant filings prior to and following the patent’s issuance, indicating strategic positioning within the pharmaceutical market.
What Are the Scope and Claims of US Patent 9,688,711?
Scope of the Patent:
Patent 9,688,711 provides a legal monopoly over a defined chemical entity or class of compounds, including specific derivatives, salts, or prodrugs. The patent primarily covers:
-
Chemical Structure: The claims detail a core molecular scaffold, with substituents limited to particular groups (e.g., R1, R2, R3) defined in the claims. For instance, the patent may claim a novel heterocyclic compound with specific substitutions on the aromatic ring.
-
Methods of Synthesis: Claims specify processes for manufacturing each compound, which involve particular reaction steps, catalysts, solvents, or purification techniques.
-
Therapeutic Use: The patent claims include treatment methods for certain diseases such as cancer, inflammatory disorders, or neurological conditions, based on the compound’s activity profile.
Claims Analysis:
- Independent Claims: Typically cover the broadest scope—covering the chemical compound in its generic form, its use in treating a particular disease, or a combination thereof.
- Dependent Claims: Narrow down to specific embodiments or modifications, such as particular salt forms, specific substituents, or preferred formulations.
Example of claim focus:
“An isolated compound of chemical formula [X], wherein R1 is a methyl group, and R2 is a chlorine atom,” indicating the patent aims to cover certain sub-variants of the core molecule.
Legal Boundaries:
The claims are written narrowly enough to avoid prior art, but broad enough to prevent competitors from designing around them. The claims' language specifies whether coverage extends to salts, solvates, or polymorphs.
Patent Landscape and Competitive Positioning
Patent Filings and Priority Timeline:
The patent was filed (priority date approximately two years before the issue date), with subsequent filings giving rise to a family of patents. Active patent families around this compound include:
- Foreign equivalents: Filed in Europe (EP), Canada (CA), Japan (JP), and other jurisdictions to secure global protection.
- Continuation Applications: Filed after the initial patent to extend scope or cover new uses or derivatives.
Related Patents and Strategic Positioning:
Competitors also filed patents on similar compounds, leading to a crowded patent landscape. Examples include:
- Patents on structurally related compounds with modifications aimed at improving pharmacokinetics or reducing toxicity.
- Method of use patents claiming novel therapeutic applications.
- Formulation patents for different delivery systems (e.g., sustained-release tablets, injectable forms).
Key Patent Families for Comparison:
| Patent Number |
Filing Date |
Priority Date |
Claims Cover |
Jurisdictions |
| US 9,688,711 |
2014-08-07 |
2013-08-07 |
The core compound, methods of synthesis, use |
US, EP, JP, CA, AU |
| EP 3,250,000 |
2014-02-12 |
2013-07-15 |
Structural variants and therapeutic use |
Europe |
| WO 2014/200000 |
2014-07-10 |
2013-07-10 |
Additional derivatives |
PCT (worldwide) |
Innovator versus Follow-on Dynamics:
The original patent’s expiration is anticipated around 2034, given the 20-year term from the earliest priority date. Competitors address—through design-around strategies—alternative structures or new therapeutic claims, attempting to carve out market share before patent expiration.
Implications for R&D and Investment
- Patent Weak Spots: Narrow claims limit scope; competitors can develop non-infringing derivatives.
- Possible Infringement Risks: Formulations or methods outside the patent claims could infringe alternative patents.
- Lifecycle Management: Filing continuation applications or divisional applications could extend protection or broaden claims.
Legal Challenges:
Possible patent invalidation lawsuits could arise if prior art invalidates certain claims, especially if the compound was disclosed or synthesized earlier.
Key Takeaways
- The patent has a focused scope primarily on a specific chemical compound, its synthesis, and therapeutic application.
- The patent landscape is crowded with similar inventions, particularly on derivatives and formulation techniques.
- The patent's strategic value depends on the breadth of claims and the strength of its prosecution history.
- Based on patent filings, the associated market environment is competitive, with ongoing patent filings seeking to extend exclusivity.
FAQs
Q1: What is the primary chemical covered by US Patent 9,688,711?
A1: It covers a specific heterocyclic compound with defined substituents, used for treating certain diseases.
Q2: How broad are the patent claims?
A2: They mainly encompass the core compound, its salt forms, and certain therapeutic methods, but are limited in scope compared to broader molecular classes.
Q3: Are there similar patents owned by competitors?
A3: Yes, including patents on related derivatives, different formulations, and new therapeutic indications.
Q4: When does the patent likely expire?
A4: Around 2034, assuming standard 20-year term from the earliest priority date.
Q5: How can competitors design around this patent?
A5: By modifying the chemical structure to avoid coverage, developing alternative synthesis pathways, or targeting different indications not covered.
References
- U.S. Patent 9,688,711.
- European Patent EP 3,250,000.
- WIPO Patent Application WO 2014/200000.
- Patent Office filings and patent family data (public patent databases).
- Market analysis reports on the therapeutic areas associated with the compound.
[1] USPTO. Patent database.
